Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV test for use in hematopoietic stem cell transplant recipients

P Ramanan, RR Razonable - Expert Review of Molecular …, 2017 - Taylor & Francis
Introduction: Cytomegalovirus (CMV) is a common opportunistic infection that contributes to
poor outcomes in hematopoietic stem cell transplant (HSCT) recipients. Prevention of CMV …
被引用次数：7 相关文章

[引用][C] Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients

P Ramanan, RR Razonable - Expert Review of Molecular Diagnostics, 2017 - cir.nii.ac.jp
Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem
cell transplant recipients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients.

P Ramanan, RR Razonable - Expert Review of Molecular …, 2017 - europepmc.org
Cytomegalovirus (CMV) is a common opportunistic infection that contributes to poor
outcomes in hematopoietic stem cell transplant (HSCT) recipients. Prevention of CMV end …

Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients

P Ramanan, RR Razonable - Expert review of molecular …, 2017 - pubmed.ncbi.nlm.nih.gov
Cytomegalovirus (CMV) is a common opportunistic infection that contributes to poor
outcomes in hematopoietic stem cell transplant (HSCT) recipients. Prevention of CMV end …

Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients

P Ramanan, RR Razonable - Expert Review of Molecular …, 2017 - ohsu.elsevierpure.com
Introduction: Cytomegalovirus (CMV) is a common opportunistic infection that contributes to
poor outcomes in hematopoietic stem cell transplant (HSCT) recipients. Prevention of CMV …

Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients

P Ramanan, RR Razonable - Expert Review of …, 2017 - mayoclinic.elsevierpure.com
Introduction: Cytomegalovirus (CMV) is a common opportunistic infection that contributes to
poor outcomes in hematopoietic stem cell transplant (HSCT) recipients. Prevention of CMV …